<?xml version="1.0" encoding="UTF-8"?>
<p>HCV prevalence in the other MENA countries (excluding Egypt and Pakistan) ranged from 0.0% to 76.2%, with a median of 11.5%. The pooled mean prevalence in all populations with LRDs was 15.6% (95% CI, 12.4%‐19.0%). The pooled mean prevalence was lowest in patients suspected of having an LRD (2.9%; 95% CI, 0.0%‐9.4%) and highest in patients with cirrhosis (25.9%; 95% CI, 17.3%‐35.6%).</p>
